| |
| |
|
| Insider
Information: |
Hutt Peter Barton |
| Relationship: |
Director |
| City: |
Irvine |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
10 |
|
| Direct
Shares |
326,743 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$408,735 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
326,743 |
|
|
| Total
Value |
$408,735 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 37.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Quick Med Technologies Inc |
QMDT |
Resigned effective 11/... |
2003-07-24 |
224,000 |
2003-07-24 |
0 |
Premium* |
|
|
Momenta Pharmaceuticals Inc |
MNTA |
Director |
2014-09-12 |
6,725 |
2004-06-25 |
0 |
Premium* |
|
|
ISTA Pharmaceuticals Inc |
ISTA |
Director |
2012-06-06 |
0 |
2004-10-20 |
0 |
Premium* |
|
|
Introgen Therapeutics Inc |
INGNQ |
Director |
2007-05-30 |
15,419 |
2006-05-23 |
0 |
Premium* |
|
|
Concert Pharmaceuticals, Inc. |
CNCE |
Director |
2023-03-06 |
0 |
2014-02-19 |
0 |
Premium* |
|
|
Salarius Pharmaceuticals, Inc |
SLRX |
Director |
2015-02-03 |
11,675 |
2015-02-03 |
0 |
Premium* |
|
|
Seres Therapeutics, Inc. |
MCRB |
Director |
2015-06-25 |
50,000 |
|
0 |
Premium* |
|
|
DNIB Upwind Inc |
BIND |
Director |
2016-08-29 |
15,000 |
2016-08-29 |
0 |
Premium* |
|
|
Immunomedics Inc |
IMMU |
Director |
2020-10-23 |
0 |
2018-04-02 |
0 |
Premium* |
|
|
Moderna, Inc. |
MRNA |
Director |
2019-11-20 |
3,924 |
2019-09-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRNA |
Moderna, Inc. |
Director |
• • – |
2019-11-20 |
4 |
OE |
$0.04 |
$8,000 |
D/D |
200,000 |
203,924 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2020-08-31 |
4 |
OE |
$3.79 |
$13,413 |
D/D |
3,539 |
7,963 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2022-10-14 |
4 |
OE |
$2.88 |
$10,192 |
D/D |
3,539 |
33,027 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2010-12-10 |
4 |
S |
$14.67 |
$916,846 |
D/D |
(62,498) |
5,365 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2010-12-14 |
4 |
S |
$14.35 |
$918,400 |
D/D |
(64,000) |
5,365 |
0 |
- |
|
| MNTA |
Momenta Pharmaceuticals I... |
Director |
– • – |
2014-09-12 |
4 |
S |
$11.42 |
$41,569 |
D/D |
(3,640) |
6,725 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2016-11-14 |
4 |
S |
$9.81 |
$217,027 |
D/D |
(22,123) |
0 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2019-08-08 |
4 |
S |
$10.31 |
$36,487 |
D/D |
(3,539) |
4,424 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Director |
• • – |
2019-09-17 |
4 |
S |
$17.63 |
$1,763,000 |
D/D |
(100,000) |
3,924 |
0 |
- |
|
| MRNA |
Moderna, Inc. |
Director |
• • – |
2019-11-20 |
4 |
S |
$20.18 |
$4,036,000 |
D/D |
(200,000) |
3,924 |
0 |
- |
|
| CNCE |
Concert Pharmaceuticals, ... |
Director |
– • – |
2022-10-14 |
4 |
S |
$6.09 |
$21,553 |
D/D |
(3,539) |
29,488 |
0 |
% |
|
36 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
